Literature DB >> 22408360

Serological and molecular study of hepatitis E virus among illegal blood donors.

Xian-Feng Cheng1, Yu-Feng Wen, Ming Zhu, Sheng-Wei Zhan, Jin-Xiu Zheng, Chen Dong, Ke-Xia Xiang, Xiao-Bing Xia, Gang Wang, Ling-Fei Han.   

Abstract

AIM: To investigate the seroprevalence and molecular characteristics of hepatitis E virus (HEV) in the illegal blood donors (IBDs) of central China in the early 1990s.
METHODS: A total of 546 blood samples were collected from the IBDs in Maanshan city, a questionnaire was completed by each subject, detailing the age, sex, and periods of blood or plasma donation. Anhui Province and tested for the anti-HEV antibodies. The seropositive samples were subjected to nested reverse transcription-polymerase chain reaction and sequencing to analyze HEV partial genome.
RESULTS: The prevalence of IgG and IgM HEV antibody in IBDs was 22.7% and 1.8%, and genotype 4 was the dominant circulating HEV type in IBDs. The prevalence of anti-HEV IgG was significantly related to sex (OR = 4.905, P = 0.004) and increased with age (OR = 2.78, P = 0.022), which ranged from 13.0% in those < 40 years old to 30.6% among older persons aged > 60 years. Moreover, frequency of blood donation was significantly associated with HEV seropositivity (OR = 2.06, P = 0.006). HEV partial sequences of ORF2 and obtained 3 sequences in serum samples of 10 IBDs which developed HEV specific IgM.
CONCLUSION: This study helps define one of the possible routes of transmission of sporadic HEV infection and provides guidance to screen HEV in the blood donors so as to guarantee safe blood banks in China.

Entities:  

Keywords:  Commercial blood donors; Hepatitis E; Hepatitis E virus; Molecular; Sero-epidemiology

Mesh:

Substances:

Year:  2012        PMID: 22408360      PMCID: PMC3297060          DOI: 10.3748/wjg.v18.i9.986

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Hepatitis E in the south west of France in individuals who have never visited an endemic area.

Authors:  Jean Michel Mansuy; Jean Marie Peron; Florence Abravanel; Hélène Poirson; Martine Dubois; Marcel Miedouge; Françoise Vischi; Laurent Alric; Jean Pierre Vinel; Jacques Izopet
Journal:  J Med Virol       Date:  2004-11       Impact factor: 2.327

2.  Running like water--the omnipresence of hepatitis E.

Authors:  Suzanne U Emerson; Robert H Purcell
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

3.  Phylogenetic analysis of hepatitis E virus isolates in southern China (1994-1998).

Authors:  Shaojing Wei; Yangbin Xu; Meifang Wang; Shing Shun Tony To
Journal:  J Clin Virol       Date:  2006-04-19       Impact factor: 3.168

4.  Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China.

Authors:  Jian-qing Xu; Jian-jun Wang; Li-feng Han; Chen Xu; Yu-hua Ruan; Zhen-hou Xu; Xi Chen; Zhen-dong Liu; Jun Wang; Bing Su; Xin-ping Ding; Bing Gao; Yong-bin Gu; Xiao-yun Cao; Hui Xing; Kun-xue Hong; Hong Peng; Quan-bi Zhao; Lin Yuan; Yi Feng; Gui-yun Zhang; Li-ying Ma; Lan Wu; Yi-ming Shao
Journal:  Chin Med J (Engl)       Date:  2006-12-05       Impact factor: 2.628

5.  Non-travel-associated hepatitis E in England and Wales: demographic, clinical, and molecular epidemiological characteristics.

Authors:  Samreen Ijaz; Eve Arnold; Malcolm Banks; Richard P Bendall; Matthew E Cramp; Richard Cunningham; Harry R Dalton; Tim J Harrison; Simon F Hill; Lorna Macfarlane; Rolf E Meigh; Shuja Shafi; Martin J Sheppard; Jacquie Smithson; Melanie P Wilson; Chong-Gee Teo
Journal:  J Infect Dis       Date:  2005-08-22       Impact factor: 5.226

6.  Epidemiology and genotypes of HEV in Wuhan.

Authors:  Yan Chen; De Ying Tian; Ning Shao Xia
Journal:  Chin J Dig Dis       Date:  2005

7.  Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma.

Authors:  Akinori Tamura; Yohko K Shimizu; Torahiko Tanaka; Kazumichi Kuroda; Yasuyuki Arakawa; Kazuaki Takahashi; Shunji Mishiro; Kazufumi Shimizu; Mitsuhiko Moriyama
Journal:  Hepatol Res       Date:  2007-02       Impact factor: 4.288

8.  Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A.

Authors:  Shigehiko Sainokami; Koichi Abe; Ichiro Kumagai; Akio Miyasaka; Ryujin Endo; Yasuhiro Takikawa; Kazuyuki Suzuki; Hitoshi Mizuo; Yoshiki Sugai; Yoshihiro Akahane; Yoichi Koizumi; Yoshiaki Yajima; Hiroaki Okamoto
Journal:  J Gastroenterol       Date:  2004-07       Impact factor: 7.527

9.  Partial nucleotide sequencing of hepatitis E viruses detected in sera of patients with hepatitis E from 14 cities in China.

Authors:  Kui Li; Hui Zhuang; Wanfu Zhu
Journal:  Chin Med J (Engl)       Date:  2002-07       Impact factor: 2.628

10.  Hepatitis E virus infection in hemodialysis patients: a seroepidemiological survey in Iran.

Authors:  Mahnaz Taremi; Manouchehr Khoshbaten; Latif Gachkar; MohammadJavad EhsaniArdakani; MohammadReza Zali
Journal:  BMC Infect Dis       Date:  2005-05-17       Impact factor: 3.090

View more
  10 in total

Review 1.  Hepatitis E: an old infection with new implications.

Authors:  Giuseppe Marano; Stefania Vaglio; Simonetta Pupella; Giuseppina Facco; Maria Bianchi; Gabriele Calizzani; Fabio Candura; Liviana Catalano; Blandina Farina; Monica Lanzoni; Vanessa Piccinini; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

2.  Novel approach for detection of hepatitis E virus infection in German blood donors.

Authors:  Tanja Vollmer; Juergen Diekmann; Reimar Johne; Matthias Eberhardt; Cornelius Knabbe; Jens Dreier
Journal:  J Clin Microbiol       Date:  2012-06-06       Impact factor: 5.948

Review 3.  Epidemiology of hepatitis E virus in Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

4.  Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012.

Authors:  Hassan Ehteram; Amitis Ramezani; Ali Eslamifar; Masoomeh Sofian; Mohammad Banifazl; Shahin Ghassemi; Arezoo Aghakhani; Parisa Mashayekhi
Journal:  Iran J Microbiol       Date:  2013-06

5.  Prevalence of Hepatitis E Virus among Adults in South-West of Iran.

Authors:  Fatemeh Farshadpour; Reza Taherkhani; Manoochehr Makvandi
Journal:  Hepat Res Treat       Date:  2015-06-23

6.  Epidemiology and associated risk factors of hepatitis e virus infection in plateau state, Nigeria.

Authors:  Surajudeen A Junaid; Samuel E Agina; Khadijah A Abubakar
Journal:  Virology (Auckl)       Date:  2014-05-27

7.  Hepatitis E Virus Prevalence among Blood Donors, Ouagadougou, Burkina Faso.

Authors:  Kuan A Traoré; Jean Bienvenue Ouoba; Hortense Rouamba; Yacouba K Nébié; Honorine Dahourou; Frédéric Rossetto; Alfred S Traoré; Nicolas Barro; Pierre Roques
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

8.  Sero-Epidemiological Study of Hepatitis E Virus among Thalassemia as High Risk Patients: A Cross-Sectional Survey in Jahrom, Southern, Iran.

Authors:  Abdolreza Sotoodeh Jahromi; Abbas Ahmadi-Vasmehjani; Hassan Zabetian; Hossein Hakimelahi; Alireza Yusefi; Mohammad Sadegh Sanie; Somayehsadat Talebnia Jahromi; Masoud Ghanei; Abdolali Sapidkar; Saiedeh Erfanian; Abdolhossien Madani; Farshid Kafilzadeh; Mohammad Kargar; Mohammad Hojjat-Farsangi
Journal:  Glob J Health Sci       Date:  2016-09-01

Review 9.  The Impact of Emerging Infectious Diseases on Chinese Blood Safety.

Authors:  Miao He; Jingxing Wang; Limin Chen; Jing Liu; Peibin Zeng
Journal:  Transfus Med Rev       Date:  2016-11-04

10.  Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran.

Authors:  Behrouz Naeimi; Farnaz Mazloom Kalimani; Ali Akbar Pourfatolah; Masoud Azimzadeh; Alireza Mankhian; Samad Akbarzadeh; Gholamreza Hajiani; Faramarz Kooshesh; Gholamreza Khamisipour
Journal:  Hepat Mon       Date:  2015-11-28       Impact factor: 0.660

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.